Edwards Lifesciences (EW) Financials: Revenue & Earnings
EW$94.38+2.60 +2.83%
$54.40B
Market Cap
52.75
P/E
31.48
Forward P/E
48
Score
Edwards Lifesciences (EW) Financials: Revenue & Earnings
EW price $94.38 +2.60 +2.83%
- Ticker
- EW
- Price
- $94.38
- Change
- +2.60 +2.83%
- Market cap ?
- $54.40B
- P/E ?
- 52.75
- Forward P/E ?
- 31.48
- Dividend yield ?
- 0.00%
- Beta ?
- 0.86
- Sector
- Healthcare
- Industry
- Medical - Devices
- Stocklytics score
- 48
- Value
- 28
- Quality
- 80
- Growth
- 36
Stocklytics score rationale: value 28, quality 80, growth 36.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2963700000 | 3435300000 | 3722800000 | 4348000000 | 4386300000 | 5232500000 | 5382400000 | 5010000000 | 5439500000 | 6067600000 |
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio…
Earnings and financials
Edwards Lifesciences Corporation (EW) trades at $94.38, with a market cap of $54.40B and a trailing P/E of 52.75. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2963700000 | 3435300000 | 3722800000 | 4348000000 | 4386300000 | 5232500000 | 5382400000 | 5010000000 | 5439500000 | 6067600000 |
Insights · Dividends · Forecast · Financials · Learn